[Featured Stock] CJ Bioscience Rises on News of Parent Company's Bio Division Sale Upward...
CJ Bioscience hit the upper price limit following news of its parent company's bio business division sale.
As of 9:46 a.m. on the 19th, CJ Bioscience was trading on the KOSDAQ market at 11,370 won, up 2,620 won (29.94%) from the previous trading day.
The previous day, it was reported that CJ CheilJedang had selected Morgan Stanley as the lead manager for the sale of its bio business division and was in contact with potential acquiring companies.
Hot Picks Today
Trump: "Ceasefire Extension Unlikely... Ceasefi...
- "Six Months After 'Mom's Touch Troublesome Woman' Incident... Franchise Says, 'S...
- "Is '2 Million Hynix' Really Possible? Brokers Raise Target Price for SK hynix [...
- 27 Ships Turn Back After US Blockade in Strait... "Search Underway on Iranian To...
- Female Game Caster Makes Bold Move After Criticism Over "Short Skirt" on Broadca...
Meritz Securities gave a positive evaluation of CJ CheilJedang's bio business division sale, citing reasons such as financial structure improvement and resolution of undervaluation.
![[Featured Stock] CJ Bioscience Rises on News of Parent Company's Bio Division Sale Upward...](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["They Said It Was 'Delicious' Milk... Is the 'List of Fake Milk Products in Korea' for Real? [Matjal X-File]"](https://cwcontent.asiae.co.kr/asiaresize/307/2023072413274517286_1690172865.jpg)
